CHC Healthcare Group
TWSE:4164

Watchlist Manager
CHC Healthcare Group Logo
CHC Healthcare Group
TWSE:4164
Watchlist
Price: 32.85 TWD -1.79% Market Closed
Market Cap: NT$6.4B

Net Margin

3.8%
Current
Declining
by 3.8%
vs 3-y average of 7.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3.8%
=
Net Income
NT$161.3m
/
Revenue
NT$4.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3.8%
=
Net Income
NT$161.3m
/
Revenue
NT$4.2B

Peer Comparison

Country Company Market Cap Net
Margin
TW
CHC Healthcare Group
TWSE:4164
6.4B TWD
Loading...
US
Mckesson Corp
NYSE:MCK
101.7B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
70.3B USD
Loading...
US
Cencora Inc
NYSE:COR
64B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
49.4B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
36.6B AUD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
63.9B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.9B USD
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
65.4B HKD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...

Market Distribution

In line with most companies in Taiwan
Percentile
44th
Based on 1 075 companies
44th percentile
3.8%
Low
-22 082.4% — 1%
Typical Range
1% — 11.1%
High
11.1% — 1 580%
Distribution Statistics
Taiwan
Min -22 082.4%
30th Percentile 1%
Median 5.3%
70th Percentile 11.1%
Max 1 580%

CHC Healthcare Group
Glance View

Market Cap
6.4B TWD
Industry
Health Care

CHC Healthcare Group engages in investment and the distribution, maintenance, and lease of radiation oncology, neuromedicine, imaging medicine, ophthalmology, and surgical instruments. The company is headquartered in Taipei City, Taipei. The company went IPO on 2011-10-18. The firm primarily involves in the agent distribution of radiation oncology, neurology, medical image and nuclear medical, as well as dental and ophthalmological equipment and instrument. The firm also offers related maintenance and leasing services, components and consumable materials and specialty consulting services. The firm deals with medical instrument with brands as Elekta, PTW, GE, Ashland, Megin, Leica, Hillrom, Sony, Ellex and Wexler, among others. The firm is also involved in the operation of pharmacy.

Intrinsic Value
57.87 TWD
Undervaluation 43%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
3.8%
=
Net Income
NT$161.3m
/
Revenue
NT$4.2B
What is CHC Healthcare Group's current Net Margin?

The current Net Margin for CHC Healthcare Group is 3.8%, which is below its 3-year median of 7.7%.

How has Net Margin changed over time?

Over the last 3 years, CHC Healthcare Group’s Net Margin has decreased from 13.7% to 3.8%. During this period, it reached a low of 3.8% on Oct 30, 2025 and a high of 13.7% on Aug 30, 2022.

Back to Top